KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Short-term Investments (2016 - 2026)

Biocryst Pharmaceuticals filings provide 16 years of Short-term Investments readings, the most recent being $185.0 million for Q4 2025.

  • On a quarterly basis, Short-term Investments fell 14.4% to $185.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $185.0 million, a 14.4% decrease, with the full-year FY2025 number at $185.0 million, down 14.4% from a year prior.
  • Short-term Investments hit $185.0 million in Q4 2025 for Biocryst Pharmaceuticals, up from $128.8 million in the prior quarter.
  • In the past five years, Short-term Investments ranged from a high of $278.3 million in Q4 2023 to a low of $3.2 million in Q4 2021.
  • Median Short-term Investments over the past 5 years was $185.0 million (2025), compared with a mean of $164.2 million.
  • Biggest five-year swings in Short-term Investments: plummeted 88.63% in 2021 and later soared 3621.76% in 2022.
  • Biocryst Pharmaceuticals' Short-term Investments stood at $3.2 million in 2021, then soared by 3621.76% to $119.5 million in 2022, then skyrocketed by 132.84% to $278.3 million in 2023, then fell by 22.35% to $216.1 million in 2024, then dropped by 14.4% to $185.0 million in 2025.
  • The last three reported values for Short-term Investments were $185.0 million (Q4 2025), $128.8 million (Q3 2025), and $172.0 million (Q2 2025) per Business Quant data.